1887

Journal of General Virology header logo

Volume 87, Issue 8

Inhibition of SUMO-independent PML oligomerization by the human cytomegalovirus IE1 protein Free

Abstract

In human cytomegalovirus-infected cells, the immediate-early IE1 protein disrupts the subnuclear structures known as the PML oncogenic domains or PODs, via the induction of PML desumoylation. This activity correlates with the functions of IE1 in transcriptional regulation and in the stimulation of lytic infection. Here, the effects of IE1 in induction of desumoylation of PML were characterized. IE1 did not interfere with the formation of sumoylated forms of PML . In assays using the sumoylated proteins, a SUMO-specific protease SENP1 desumoylated both PML and IE1. However, the IE1 proteins generated from bacteria or insect cells were unable to desumoylate PML in the same conditions. Although both IE1 and SUMO proteases such as SENP1, Axam and SuPr-1 efficiently desumoylated PML in co-transfection assays, they exerted different effects on the localization of PML. In cells transfected with either SENP1 or SuPr-1, the number of PML foci was reduced significantly and these remnant PML foci were devoid of SUMO-1 signals. However, in cells co-transfected with both SUMO proteases and IE1, these SUMO-independent PML foci were also completely disrupted. Furthermore, IE1, but not SENP1, was shown to disrupt the PML foci generated via transfection of a sumoylation-deficient mutant of PML. These data suggest that IE1 exhibits neither an inhibitory effect on sumoylation of PML nor intrinsic SUMO protease activity against PML . The finding that IE1 is capable of disrupting SUMO-independent PML aggregates suggests that inhibition of PML oligomerization by IE1 may play an important role in inducing PML desumoylation .

  • Received:
  • Accepted:
  • Published Online:
SGM
Loading

Article metrics loading...

/content/journal/jgv/10.1099/vir.0.81787-0
2006-08-01
2024-04-19
Loading full text...

Full text loading...

/deliver/fulltext/jgv/87/8/2181.html?itemId=/content/journal/jgv/10.1099/vir.0.81787-0&mimeType=html&fmt=ahah

References

  1. Adamson A. L., Kenney S. 2001; Epstein–Barr virus immediate-early protein BZLF1 is SUMO-1 modified and disrupts promyelocytic leukemia bodies. J Virol 75:2388–2399 [CrossRef]
     [Google Scholar]
  2. Ahn J.-H., Hayward G. S. 1997; The major immediate-early proteins IE1 and IE2 of human cytomegalovirus colocalize with and disrupt PML-associated nuclear bodies at very early times in infected permissive cells. J Virol 71:4599–4613
     [Google Scholar]
  3. Ahn J.-H., Hayward G. S. 2000; Disruption of PML-associated nuclear bodies by IE1 correlates with efficient early stages of viral gene expression and DNA replication in human cytomegalovirus infection. Virology 274:39–55 [CrossRef]
     [Google Scholar]
  4. Ahn J.-H., Brignole E. J. III, Hayward G. S. 1998; Disruption of PML subnuclear domains by the acidic IE1 protein of human cytomegalovirus is mediated through interaction with PML and may modulate a RING finger-dependent cryptic transactivator function of PML. Mol Cell Biol 18:4899–4913
     [Google Scholar]
  5. Ahn J. H., Xu Y., Jang W.-J., Matunis M. J., Hayward G. S. 2001; Evaluation of interactions of human cytomegalovirus immediate-early IE2 regulatory protein with small ubiquitin-like modifiers and their conjugation enzyme Ubc9. J Virol 75:3859–3872 [CrossRef]
     [Google Scholar]
  6. Bailey D., O'Hare P. 2002; Herpes simplex virus 1 ICP0 co-localizes with a SUMO-specific protease. J Gen Virol 83:2951–2964
     [Google Scholar]
  7. Bailey D., O'Hare P. 2004; Characterization of the localization and proteolytic activity of the SUMO-specific protease, SENP1. J Biol Chem 279:692–703 [CrossRef]
     [Google Scholar]
  8. Bell P., Lieberman P. M., Maul G. G. 2000; Lytic but not latent replication of Epstein–Barr virus is associated with PML and induces sequential release of nuclear domain 10 proteins. J Virol 74:11800–11810 [CrossRef]
     [Google Scholar]
  9. Bernardi R., Pandolfi P. P. 2003; Role of PML and the PML-nuclear body in the control of programmed cell death. Oncogene 22:9048–9057 [CrossRef]
     [Google Scholar]
  10. Boutell C., Orr A., Everett R. D. 2003; PML residue lysine 160 is required for the degradation of PML induced by herpes simplex virus type 1 regulatory protein ICP0. J Virol 77:8686–8694 [CrossRef]
     [Google Scholar]
  11. Dellaire G., Bazett-Jones D. P. 2004; PML nuclear bodies: dynamic sensors of DNA damage and cellular stress. Bioessays 26:963–977 [CrossRef]
     [Google Scholar]
  12. Everett R. D., Maul G. G. 1994; HSV-1 IE protein Vmw110 causes redistribution of PML. EMBO J 13:5062–5069
     [Google Scholar]
  13. Gawn J. M., Greaves R. F. 2002; Absence of IE1 p72 protein function during low-multiplicity infection by human cytomegalovirus results in a broad block to viral delayed-early gene expression. J Virol 76:4441–4455 [CrossRef]
     [Google Scholar]
  14. Gravel A., Gosselin J., Flamand L. 2002; Human herpesvirus 6 immediate-early 1 protein is a sumoylated nuclear phosphoprotein colocalizing with promyelocytic leukemia protein-associated nuclear bodies. J Biol Chem 277:19679–19687 [CrossRef]
     [Google Scholar]
  15. Greaves R. F., Mocarski E. S. 1998; Defective growth correlates with reduced accumulation of a viral DNA replication protein after low-multiplicity infection by a human cytomegalovirus ie1 mutant. J Virol 72:366–379
     [Google Scholar]
  16. Green S., Isseman P., Sheer E. 1988; A versatile in vivo and in vitro eukaryotic expression vector for protein engineering. Nucleic Acids Res 16:369 [CrossRef]
     [Google Scholar]
  17. Ishov A. M., Sotnikov A. G., Negorev D., Vladimirova O. V., Neff N., Kamitani T., Yeh E. T. H., Strauss J. F. III, Maul G. G. 1999; PML is critical for ND10 formation and recruits the PML-interacting protein Daxx to this nuclear structure when modified by SUMO-1. J Cell Biol 147:221–234 [CrossRef]
     [Google Scholar]
  18. Johnson E. S. 2004; Protein modification by SUMO. Annu Rev Biochem 73:355–382 [CrossRef]
     [Google Scholar]
  19. Kamitani T., Kito K., Nguyen H. P., Wada H., Fukuda-Kamitani T., Yeh E. T. H. 1998; Identification of three major sentrinization sites in PML. J Biol Chem 273:26675–26682 [CrossRef]
     [Google Scholar]
  20. Kentsis A., Gordon R. E., Borden K. L. 2002; Control of biochemical reactions through supramolecular RING domain self-assembly. Proc Natl Acad Sci U S A 99:15404–15409 [CrossRef]
     [Google Scholar]
  21. Korioth F., Maul G. G., Plachter B., Stamminger T., Frey J. 1996; The nuclear domain 10 (ND10) is disrupted by the human cytomegalovirus gene product IE1. Exp Cell Res 229:155–158 [CrossRef]
     [Google Scholar]
  22. Lallemand-Breitenbach V., Zhu J., Puvion F. & 8 other authors 2001; Role of promyelocytic leukemia (PML) sumolation in nuclear body formation, 11S proteasome recruitment, and As2O3-induced PML or PML/retinoic acid receptor α degradation. J Exp Med 193:1361–1371 [CrossRef]
     [Google Scholar]
  23. Lee H.-R., Kim D.-J., Lee J.-M., Choi C. Y., Ahn B.-Y., Hayward G. S., Ahn J.-H. 2004; Ability of the human cytomegalovirus IE1 protein to modulate sumoylation of PML correlates with its functional activities in transcriptional regulation and infectivity in cultured fibroblast cells. J Virol 78:6527–6542 [CrossRef]
     [Google Scholar]
  24. Maul G. G., Everett R. D. 1994; The nuclear location of PML, a cellular member of the C3HC4 zinc-binding domain protein family, is rearranged during herpes simplex virus infection by the C3HC4 viral protein ICP0. J Gen Virol 75:1223–1233 [CrossRef]
     [Google Scholar]
  25. Maul G. G., Guldner H. H., Spivack J. G. 1993; Modification of discrete nuclear domains induced by herpes simplex virus type 1 immediate early gene 1 product (ICP0). J Gen Virol 74:2679–2690 [CrossRef]
     [Google Scholar]
  26. Mocarski E. S., Tan Courcelle C. 2001; Cytomegalovirus and their replication. In Fields Virology , 4th edn. pp  2629–2673 Edited by Knipe D. M., Howley P. M. Philadelphia, PA: Lippincott Williams & Wilkins;
     [Google Scholar]
  27. Mocarski E. S., Kemble G. W., Lyle J. M., Greaves R. F. 1996; A deletion mutant in the human cytomegalovirus gene encoding IE1491aa is replication defective due to a failure in autoregulation. Proc Natl Acad Sci U S A 93:11321–11326 [CrossRef]
     [Google Scholar]
  28. Müller S., Dejean A. 1999; Viral immediate-early proteins abrogate the modification by SUMO-1 of PML and Sp100 proteins, correlating with nuclear body disruption. J Virol 73:5137–5143
     [Google Scholar]
  29. Nefkens I., Negorev D. G., Ishov A. M., Michaelson J. S., Yeh E. T. H., Tanguay R. M., Müller W. E. G., Maul G. G. 2003; Heat shock and Cd2+ exposure regulate PML and Daxx release from ND10 by independent mechanisms that modify the induction of heat-shock proteins 70 and 25 differently. J Cell Sci 116:513–524 [CrossRef]
     [Google Scholar]
  30. Nevels M., Brune W., Shenk T. 2004; SUMOylation of the human cytomegalovirus 72-kilodalton IE1 protein facilitates expression of the 86-kilodalton IE2 protein and promotes viral replication. J Virol 78:7803–7812 [CrossRef]
     [Google Scholar]
  31. Pass R. F. 2001; Cytomegalovirus. In Fields Virology . , 4th edn. pp  2675–2705 Edited by Knipe D. M., Howley P. M. Philadelphia, PA: Lippincott Williams & Wilkins;
  32. Regad T., Saib A., Lallemand-Breitenbach V., Pandolfi P. P., de Thé H., Chelbi-Alix M. K. 2001; PML mediates the interferon-induced antiviral state against a complex retrovirus via its association with the viral transactivator. EMBO J 20:3495–3505 [CrossRef]
     [Google Scholar]
  33. Roth M. B., Zahler A. M., Stolk J. A. 1991; A conserved family of nuclear phosphoproteins localized to sites of polymerase II transcription. J Cell Biol 115:587–596 [CrossRef]
     [Google Scholar]
  34. Sadanari H., Yamada R., Ohnishi K., Matsubara K., Tanaka J. 2005; SUMO-1 modification of the major immediate-early (IE) 1 and 2 proteins of human cytomegalovirus is regulated by different mechanisms and modulates the intracellular localization of the IE1, but not IE2, protein. Arch Virol 150:1763–1782 [CrossRef]
     [Google Scholar]
  35. Salomoni P., Pandolfi P. P. 2002; The role of PML in tumor suppression. Cell 108:165–170 [CrossRef]
     [Google Scholar]
  36. Seeler J.-S., Dejean A. 2003; Nuclear and unclear functions of SUMO. Nat Rev Mol Cell Biol 4:690–699 [CrossRef]
     [Google Scholar]
  37. Spengler M. L., Kurapatwinski K., Black A. R., Azizkhan-Clifford J. 2002; SUMO-1 modification of human cytomegalovirus IE1/IE72. J Virol 76:2990–2996 [CrossRef]
     [Google Scholar]
  38. Stanton R., Fox J. D., Caswell R., Sherratt E., Wilkinson G. W. G. 2002; Analysis of the human herpesvirus-6 immediate-early 1 protein. J Gen Virol 83:2811–2820
     [Google Scholar]
  39. Tang Q., Maul G. G. 2003; Mouse cytomegalovirus immediate-early protein 1 binds with host cell repressors to relieve suppressive effects on viral transcription and replication during lytic infection. J Virol 77:1357–1367 [CrossRef]
     [Google Scholar]
  40. Tatham M. H., Jaffray E., Vaughan O. A., Desterro J. M. P., Botting C. H., Naismith J. H., Hay R. T. 2001; Polymeric chains of SUMO-2 and SUMO-3 are conjugated to protein substrates by SAE1/SAE2 and Ubc9. J Biol Chem 276:35368–35374 [CrossRef]
     [Google Scholar]
  41. Uchimura Y., Nakamura M., Sugasawa K., Nakao M., Saitoh H. 2004a; Overproduction of eukaryotic SUMO-1- and SUMO-2-conjugated proteins in Escherichia coli . Anal Biochem 331:204–206 [CrossRef]
     [Google Scholar]
  42. Uchimura Y., Nakao M., Saitoh H. 2004b; Generation of SUMO-1 modified proteins in E. coli : towards understanding the biochemistry/structural biology of the SUMO-1 pathway. FEBS Lett 564:85–90 [CrossRef]
     [Google Scholar]
  43. Wilkinson G. W., Kelly C., Sinclair J. H., Rickards C. 1998; Disruption of PML-associated nuclear bodies mediated by the human cytomegalovirus major immediate early gene product. J Gen Virol 79:1233–1245
     [Google Scholar]
  44. Xu Y., Ahn J.-H., Cheng M., apRhys C. M., Chiou C.-J., Zong J., Matunis M. J., Hayward G. S. 2001; Proteasome-independent disruption of PML oncogenic domains (PODs), but not covalent modification by SUMO-1, is required for human cytomegalovirus immediate-early protein IE1 to inhibit PML-mediated transcriptional repression. J Virol 75:10683–10695 [CrossRef]
     [Google Scholar]
  45. Zhong S., Muller S., Ronchetti S., Freemont P. S., Dejean A., Pandolfi P. P. 2000a; Role of SUMO-1-modified PML in nuclear body formation. Blood 95:2748–2752
     [Google Scholar]
  46. Zhong S., Salomoni P., Pandolfi P. P. 2000b; The transcriptional role of PML and the nuclear body. Nat Cell Biol 2:E85–E90 [CrossRef]
     [Google Scholar]
http://instance.metastore.ingenta.com/content/journal/jgv/10.1099/vir.0.81787-0
Loading
Inhibition of SUMO-independent PML oligomerization by the human cytomegalovirus IE1 protein
J. Gen. Virol. 87, 2181 (2006); https://doi.org/10.1099/vir.0.81787-0
/content/journal/jgv/10.1099/vir.0.81787-0
/content/journal/jgv/10.1099/vir.0.81787-0
Loading

Data & Media loading...

Most cited Most Cited RSS feed

This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error